Hikma Pharmaceutical reported 2.45B in Equity Capital and Reserves for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Artemis Alpha ATS:LN 159.16M 22.66M
AstraZeneca AZN:LN 36340M 2928M
Bayer BAYN:GR € 37437M 4417M
Fresenius FRE:GR € 19870M 872M
Fresenius Medical Care FMS:US $ 13234.5M 535.71M
Galapagos GLPG:NA € 2646.59M 3.23M
Genmab GEN:DC DK 22719M 523M
GlaxoSmithKline GSK:LN 16181M 1126M
GRIFOLS GRF:SM € 5168.17M 254.92M
H. Lundbeck A/S LUN:DC 18.45B 167M
Hikma Pharmaceutical HIK:LN 2.45B 163M
Lonza Group LONN:SW 9.75B 2.48B
Merck MRK:GR € 22919M 1581M
Orion ORNBV:FH € 639.9M 108M
Recordati REC:IM € 1449.43M 67.81M